[1]Li J, et al. JAMA NetwOpen. 2023 Jun 1;6(6):e2321388
[2]Sheffield KM, et al. Future Oncol 2022;18(21):2667-2682.[3]Pan H, et al.N Engl J Med. 2017;377(19):1836-1846.[4]Pagani O, et al. j Clin Oncol. 2020 Apr 20;38(12):1293-1303.[5]Trial Assigning Individualized Options for Treatment(TAlLORx): An Update Including 12-Year Event Rates .2022SABCS. Abstract GS1-05.[6]NCCN. Clinical Practice Guidelines in Oncology. Breast cancer, version 6.2024. Accessed November 21, 2024. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf